SC
CLB icon

Stephens Consulting’s Core Laboratories CLB Stock Holding History

Stephens Consulting’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25
Closed -$375 – 1349
2025
Q1 		$375 Buy
+25
New +$419 ﹤0.01% 1165

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Stephens Consulting's CLB Position: Q2 2025 in Review

Stephens Consulting sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 25 shares — an estimated $375 sold.

Stephens Consulting first reported a position in CLB in Q1 2025 and held it in 1 quarter. The position peaked at $375 in Q1 2025. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

  • Stephens Consulting reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 25 Core Laboratories shares in Q2 2025, an estimated $375.
  • Stephens Consulting first reported a position in Core Laboratories in Q1 2025 and held it in 1 quarter.
  • Stephens Consulting's Core Laboratories position peaked at $375 in Q1 2025.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.